Sign In

Login

Password

Forgot Password ? Sign Up

Ivermectin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ivermectin" in German language version.

refsWebsite
Global rank German rank
19doi.org
2nd place
3rd place
14nih.gov
4th place
7th place
3web.archive.org
1st place
1st place
3redirecter.toolforge.org
33rd place
2nd place
3aerzteblatt.de
3,043rd place
200th place
3theguardian.com
12th place
25th place
2pharmazeutische-zeitung.de
8,614th place
583rd place
2sciencebasedmedicine.org
5,063rd place
low place
2fda.gov
447th place
751st place
2rki.de
4,845th place
310th place
2sahpra.org.za
low place
low place
1merck.com
6,464th place
low place
1sigmaaldrich.com
924th place
87th place
1thieme.de
low place
1,735th place
1spektrum.de
1,960th place
130th place
1mectizan.org
low place
low place
1google.de
2,106th place
139th place
1monash.edu
low place
low place
1quarks.de
low place
3,244th place
1medizin-transparent.at
low place
2,661st place
1bbc.com
20th place
57th place
1researchsquare.com
low place
low place
1science.org
1,160th place
2,116th place
1who.int
195th place
255th place
1europa.eu
68th place
29th place
1nhk.or.jp
145th place
2,334th place
1jpost.com
544th place
977th place
1newsweek.com
269th place
601st place
1basg.gv.at
low place
low place
1rstmh.org
low place
low place
1trialsitenews.com
low place
low place
1mzcr.cz
low place
low place
1usatoday.com
41st place
174th place
1indiatoday.in
94th place
3,862nd place
1n-tv.de
1,071st place
60th place
1cdc.gov
218th place
968th place
1spiegel.de
66th place
4th place
1zeit.de
267th place
15th place
1luzernerzeitung.ch
8,534th place
672nd place
1nzz.ch
687th place
41st place
1afp.com
6,649th place
6,273rd place
1cpsa.ca
low place
low place

aerzteblatt.de (Global: 3,043rd place; German: 200th place)

afp.com (Global: 6,649th place; German: 6,273rd place)

factcheck.afp.com

basg.gv.at (Global: low place; German: low place)

bbc.com (Global: 20th place; German: 57th place)

cdc.gov (Global: 218th place; German: 968th place)

emergency.cdc.gov

cpsa.ca (Global: low place; German: low place)

doi.org (Global: 2nd place; German: 3rd place)

  • David Molyneux, Hugh R. Taylor: The discovery of ivermectin. In: Trends in Parasitology. Band 31, Nr. 1, 2015, doi:10.1016/j.pt.2014.10.003, PMID 25457939.
  • A. Estrada-Mondragon, J. W. Lynch: Functional characterization of ivermectin binding sites in α1β2γ2L GABA(A) receptors. In: Frontiers in molecular neuroscience, 2015, 8, S. 55. doi:10.3389/fnmol.2015.00055, PMC 4585179 (freier Volltext)
  • David M. Pariser et al.: Topical 0.5 % ivermectin lotion for treatment of head lice. In: The New England Journal of Medicine. Band 367, Nr. 18, 1. November 2012, S. 1687–1693, doi:10.1056/NEJMoa1200107, PMID 23113480.
  • Wolfram G. Metzger et al.: Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial. In: Tropical medicine & international health: TM & IH. Band 25, Nr. 3, März 2020, S. 380–386, doi:10.1111/tmi.13357, PMID 31808594.
  • Leon Calya et al.: The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. In: Antiviral Research. Band 178, Juni 2020, S. 104787, doi:10.1016/j.antiviral.2020.104787 (englisch).
  • Mike Bray et al.: Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses. In: Antiviral Research. Band 178, Juni 2020, S. 104805, doi:10.1016/j.antiviral.2020.104805, PMID 32330482, PMC 7172803 (freier Volltext).
  • Eduardo López-Medina et al.: Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. In: JAMA. Band 325, Nr. 14, 13. April 2021, S. 1426–1435, doi:10.1001/jama.2021.3071, PMID 33662102, PMC 7934083 (freier Volltext).
  • Luis Ignacio Garegnani et al.: Misleading clinical evidence and systematic reviews on ivermectin for COVID-19. In: BMJ Evidence-Based Medicine. 22. April 2021, doi:10.1136/bmjebm-2021-111678, PMID 33888547.
  • Jack M. Lawrence et al.: The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable. In: Nature Medicine. 22. September 2021, S. 1–2, doi:10.1038/s41591-021-01535-y, PMID 34552263.
  • Jessica J. Bartoszko et al.: Prophylaxis against covid-19: living systematic review and network meta-analysis. In: BMJ. Band 373, 26. April 2021, S. n949, doi:10.1136/bmj.n949, PMID 33903131, PMC 8073806 (freier Volltext).
  • Yuani M. Roman et al.: Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials. In: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 28. Juni 2021, doi:10.1093/cid/ciab591, PMID 34181716.
  • Marcelo Beltrão Molento: Ivermectin against COVID-19: The unprecedented consequences in Latin America. In: One Health (Amsterdam, Netherlands). Band 13, April 2021, S. 100250, doi:10.1016/j.onehlt.2021.100250, PMID 33880395, PMC 8050401 (freier Volltext) – (englisch).
  • Sara Reardon: Flawed ivermectin preprint highlights challenges of COVID drug studies. In: Nature. Band 596, Nr. 7871, 2. August 2021, S. 173–174, doi:10.1038/d41586-021-02081-w.
  • Maria Popp et al.: Ivermectin for preventing and treating COVID-19. In: The Cochrane Database of Systematic Reviews. Band 7, 28. Juli 2021, S. CD015017, doi:10.1002/14651858.CD015017.pub2, PMID 34318930 (englisch).
  • Maria Popp et al.: Ivermectin for preventing and treating COVID-19. In: The Cochrane Database of Systematic Reviews. Band 6, 21. Juni 2022, S. CD015017, doi:10.1002/14651858.CD015017.pub3, PMID 35726131, PMC 9215332 (freier Volltext) – (englisch).
  • Avi Bitterman et al.: Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis. In: JAMA Network Open. Band 5, Nr. 3, 21. März 2022, S. e223079–e223079, doi:10.1001/jamanetworkopen.2022.3079.
  • Torsten Feldt et al.: Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19. Hrsg.: Robert Koch-Institut. 8. Februar 2023, S. 37, doi:10.25646/6539.26 (rki.de [PDF]).
  • Fachgruppe COVRIIN: Medikamentöse Therapie bei COVID-19 mit Bewertung durch die Fachgruppe COVRIIN am Robert Koch-Institut. Hrsg.: Robert Koch-Institut. 7. März 2022, S. 15, doi:10.25646/7743.19 (rki.de [PDF]).
  • Emiliano Rodríguez Mega: Latin America’s embrace of an unproven COVID treatment is hindering drug trials. In: Nature. Band 586, 20. Oktober 2020, S. 481–482, doi:10.1038/d41586-020-02958-2 (englisch).

europa.eu (Global: 68th place; German: 29th place)

ema.europa.eu

fda.gov (Global: 447th place; German: 751st place)

google.de (Global: 2,106th place; German: 139th place)

books.google.de

indiatoday.in (Global: 94th place; German: 3,862nd place)

jpost.com (Global: 544th place; German: 977th place)

  • Ivermectin for coronavirus? Neigh. In: jpost.com. 6. September 2021, abgerufen am 7. September 2021 (englisch): „A store in Las Vegas announced that it will allow customers to buy this drug intended for horses, yet only if the buyer presents a picture posing with the horse.“

luzernerzeitung.ch (Global: 8,534th place; German: 672nd place)

mectizan.org (Global: low place; German: low place)

medizin-transparent.at (Global: low place; German: 2,661st place)

merck.com (Global: 6,464th place; German: low place)

monash.edu (Global: low place; German: low place)

mzcr.cz (Global: low place; German: low place)

n-tv.de (Global: 1,071st place; German: 60th place)

newsweek.com (Global: 269th place; German: 601st place)

nhk.or.jp (Global: 145th place; German: 2,334th place)

www3.nhk.or.jp

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • David Molyneux, Hugh R. Taylor: The discovery of ivermectin. In: Trends in Parasitology. Band 31, Nr. 1, 2015, doi:10.1016/j.pt.2014.10.003, PMID 25457939.
  • A. Estrada-Mondragon, J. W. Lynch: Functional characterization of ivermectin binding sites in α1β2γ2L GABA(A) receptors. In: Frontiers in molecular neuroscience, 2015, 8, S. 55. doi:10.3389/fnmol.2015.00055, PMC 4585179 (freier Volltext)
  • David M. Pariser et al.: Topical 0.5 % ivermectin lotion for treatment of head lice. In: The New England Journal of Medicine. Band 367, Nr. 18, 1. November 2012, S. 1687–1693, doi:10.1056/NEJMoa1200107, PMID 23113480.
  • Wolfram G. Metzger et al.: Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial. In: Tropical medicine & international health: TM & IH. Band 25, Nr. 3, März 2020, S. 380–386, doi:10.1111/tmi.13357, PMID 31808594.
  • Mike Bray et al.: Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses. In: Antiviral Research. Band 178, Juni 2020, S. 104805, doi:10.1016/j.antiviral.2020.104805, PMID 32330482, PMC 7172803 (freier Volltext).
  • Eduardo López-Medina et al.: Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. In: JAMA. Band 325, Nr. 14, 13. April 2021, S. 1426–1435, doi:10.1001/jama.2021.3071, PMID 33662102, PMC 7934083 (freier Volltext).
  • Luis Ignacio Garegnani et al.: Misleading clinical evidence and systematic reviews on ivermectin for COVID-19. In: BMJ Evidence-Based Medicine. 22. April 2021, doi:10.1136/bmjebm-2021-111678, PMID 33888547.
  • Jack M. Lawrence et al.: The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable. In: Nature Medicine. 22. September 2021, S. 1–2, doi:10.1038/s41591-021-01535-y, PMID 34552263.
  • Jessica J. Bartoszko et al.: Prophylaxis against covid-19: living systematic review and network meta-analysis. In: BMJ. Band 373, 26. April 2021, S. n949, doi:10.1136/bmj.n949, PMID 33903131, PMC 8073806 (freier Volltext).
  • Yuani M. Roman et al.: Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials. In: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 28. Juni 2021, doi:10.1093/cid/ciab591, PMID 34181716.
  • Marcelo Beltrão Molento: Ivermectin against COVID-19: The unprecedented consequences in Latin America. In: One Health (Amsterdam, Netherlands). Band 13, April 2021, S. 100250, doi:10.1016/j.onehlt.2021.100250, PMID 33880395, PMC 8050401 (freier Volltext) – (englisch).
  • Maria Popp et al.: Ivermectin for preventing and treating COVID-19. In: The Cochrane Database of Systematic Reviews. Band 7, 28. Juli 2021, S. CD015017, doi:10.1002/14651858.CD015017.pub2, PMID 34318930 (englisch).
  • Maria Popp et al.: Ivermectin for preventing and treating COVID-19. In: The Cochrane Database of Systematic Reviews. Band 6, 21. Juni 2022, S. CD015017, doi:10.1002/14651858.CD015017.pub3, PMID 35726131, PMC 9215332 (freier Volltext) – (englisch).

covid19treatmentguidelines.nih.gov

  • Ivermectin. Covid-19 treatment guidelines. In: NIH. 29. April 2022, abgerufen am 29. Juli 2022 (englisch).

nzz.ch (Global: 687th place; German: 41st place)

pharmazeutische-zeitung.de (Global: 8,614th place; German: 583rd place)

quarks.de (Global: low place; German: 3,244th place)

redirecter.toolforge.org (Global: 33rd place; German: 2nd place)

  • Ivermectin History. Stanford University, archiviert vom Original (nicht mehr online verfügbar) am 11. Februar 2021; abgerufen am 31. August 2021.
  • Infectopharm AT: Gebrauchsinformation Scabioral. (PDF) In: Gebrauchsinformation. Infectopharm AT, März 2019, archiviert vom Original am 15. Februar 2017; abgerufen im Mai 2016.
  • Ministerstvo zdravotníctva Slovenskej republiky. Archiviert vom Original (nicht mehr online verfügbar) am 17. Juli 2021; abgerufen am 1. Februar 2021.

researchsquare.com (Global: low place; German: low place)

rki.de (Global: 4,845th place; German: 310th place)

  • Torsten Feldt et al.: Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19. Hrsg.: Robert Koch-Institut. 8. Februar 2023, S. 37, doi:10.25646/6539.26 (rki.de [PDF]).
  • Fachgruppe COVRIIN: Medikamentöse Therapie bei COVID-19 mit Bewertung durch die Fachgruppe COVRIIN am Robert Koch-Institut. Hrsg.: Robert Koch-Institut. 7. März 2022, S. 15, doi:10.25646/7743.19 (rki.de [PDF]).

rstmh.org (Global: low place; German: low place)

sahpra.org.za (Global: low place; German: low place)

science.org (Global: 1,160th place; German: 2,116th place)

sciencebasedmedicine.org (Global: 5,063rd place; German: low place)

sigmaaldrich.com (Global: 924th place; German: 87th place)

spektrum.de (Global: 1,960th place; German: 130th place)

spiegel.de (Global: 66th place; German: 4th place)

theguardian.com (Global: 12th place; German: 25th place)

thieme.de (Global: low place; German: 1,735th place)

roempp.thieme.de

trialsitenews.com (Global: low place; German: low place)

usatoday.com (Global: 41st place; German: 174th place)

web.archive.org (Global: 1st place; German: 1st place)

  • Ivermectin History. Stanford University, archiviert vom Original (nicht mehr online verfügbar) am 11. Februar 2021; abgerufen am 31. August 2021.
  • Infectopharm AT: Gebrauchsinformation Scabioral. (PDF) In: Gebrauchsinformation. Infectopharm AT, März 2019, archiviert vom Original am 15. Februar 2017; abgerufen im Mai 2016.
  • Ministerstvo zdravotníctva Slovenskej republiky. Archiviert vom Original (nicht mehr online verfügbar) am 17. Juli 2021; abgerufen am 1. Februar 2021.

who.int (Global: 195th place; German: 255th place)

zeit.de (Global: 267th place; German: 15th place)